Home/Filings/4/0001209191-21-065647
4//SEC Filing

Bondurant William 4

Accession 0001209191-21-065647

CIK 0001433714other

Filed

Nov 17, 7:00 PM ET

Accepted

Nov 18, 7:51 PM ET

Size

29.1 KB

Accession

0001209191-21-065647

Insider Transaction Report

Form 4
Period: 2021-11-16
Bondurant William
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Class B Common Stock

    2021-11-16+3,125321,326 total
  • Exercise/Conversion

    Restricted Stock Units (RSU)

    2021-11-163,1259,375 total
    Class B Common Stock (3,125 underlying)
  • Exercise/Conversion

    Restricted Stock Units (RSU)

    2021-11-161,2503,750 total
    Class B Common Stock (1,250 underlying)
  • Exercise/Conversion

    Restricted Stock Units (RSU)

    2021-11-1617,606140,846 total
    Class B Common Stock (17,606 underlying)
  • Exercise/Conversion

    Restricted Stock Units (RSU)

    2021-11-1618,750168,750 total
    Class B Common Stock (18,750 underlying)
  • Exercise/Conversion

    Restricted Stock Units (RSU)

    2021-11-1616,031208,407 total
    Class B Common Stock (16,031 underlying)
  • Exercise/Conversion

    Class B Common Stock

    2021-11-16+17,606342,994 total
  • Exercise/Conversion

    Class B Common Stock

    2021-11-16+1,250322,576 total
  • Sale

    Class B Common Stock

    2021-11-17$1.77/sh22,114$39,162355,661 total
  • Exercise/Conversion

    Class B Common Stock

    2021-11-16+2,812325,388 total
  • Exercise/Conversion

    Class B Common Stock

    2021-11-16+18,750361,744 total
  • Exercise/Conversion

    Class B Common Stock

    2021-11-16+16,031377,775 total
  • Exercise/Conversion

    Restricted Stock Units (RSU)

    2021-11-162,81214,063 total
    Class B Common Stock (2,812 underlying)
Footnotes (8)
  • [F1]Represents the aggregate number of shares sold by the Reporting Person to cover taxes and fees due upon the release and settlement of the RSUs. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees.
  • [F2]Represents the weighted average sales price per share. The shares sold at prices ranging from $1.755 to $1.835 shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
  • [F3]Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration.
  • [F4]1/16th of the RSUs vested on November 16, 2018, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
  • [F5]1/16th of the RSUs vested on May 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
  • [F6]1/16th of the RSUs vested on February 16, 2020, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
  • [F7]1/16th of the RSUs vested on May 16, 2020 and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
  • [F8]1/16th of the RSUs vested on May 16, 2021, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.

Issuer

CASTLIGHT HEALTH, INC.

CIK 0001433714

Entity typeother

Related Parties

1
  • filerCIK 0001792295

Filing Metadata

Form type
4
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 7:51 PM ET
Size
29.1 KB